PI3K inhibitors: review and new strategies

M Zhang, H Jang, R Nussinov - Chemical science, 2020 - pubs.rsc.org
The search is on for effective specific inhibitors for PI3Kα mutants. PI3Kα, a critical lipid
kinase, has two subunits, catalytic and inhibitory. PIK3CA, the gene that encodes the p110α …

Along the allostery stream: Recent advances in computational methods for allosteric drug discovery

D Ni, Z Chai, Y Wang, M Li, Z Yu, Y Liu… - Wiley …, 2022 - Wiley Online Library
Allostery is a universal, biological phenomenon in which orthosteric sites are fine‐tuned by
topologically distal allosteric sites triggered by perturbations, such as ligand binding, residue …

MutaBind2: predicting the impacts of single and multiple mutations on protein-protein interactions

N Zhang, Y Chen, H Lu, F Zhao, RV Alvarez… - Iscience, 2020 - cell.com
Missense mutations may affect proteostasis by destabilizing or over-stabilizing protein
complexes and changing the pathway flux. Predicting the effects of stabilizing mutations on …

Integrated computational approaches and tools for allosteric drug discovery

O Sheik Amamuddy, W Veldman, C Manyumwa… - International journal of …, 2020 - mdpi.com
Understanding molecular mechanisms underlying the complexity of allosteric regulation in
proteins has attracted considerable attention in drug discovery due to the benefits and …

Allosteric drugs and mutations: chances, challenges, and necessity

E Guarnera, IN Berezovsky - Current opinion in structural biology, 2020 - Elsevier
Highlights•Allosteric drugs have become an indispensable tool in precision medicine.•Major
targets for allosteric drugs: diversity structures and functions.•Allosteric effects of mutations …

[HTML][HTML] Allostery: allosteric cancer drivers and innovative allosteric drugs

R Nussinov, M Zhang, R Maloney, Y Liu, CJ Tsai… - Journal of molecular …, 2022 - Elsevier
Here, we discuss the principles of allosteric activating mutations, propagation downstream of
the signals that they prompt, and allosteric drugs, with examples from the Ras signaling …

Emergence of allosteric drug-resistance mutations: new challenges for allosteric drug discovery

S Lu, Y Qiu, D Ni, X He, J Pu, J Zhang - Drug discovery today, 2020 - Elsevier
Highlights•Allosteric drug discovery is gaining increasing attention.•Allosteric drug-
resistance mutations hamper the application of allosteric drugs.•We review the emergence …

AlloSigMA 2: paving the way to designing allosteric effectors and to exploring allosteric effects of mutations

ZW Tan, E Guarnera, WV Tee… - Nucleic acids …, 2020 - academic.oup.com
The AlloSigMA 2 server provides an interactive platform for exploring the allosteric signaling
caused by ligand binding and/or mutations, for analyzing the allosteric effects of mutations …

DeepAlloDriver: a deep learning-based strategy to predict cancer driver mutations

Q Song, M Li, Q Li, X Lu, K Song, Z Zhang… - Nucleic acids …, 2023 - academic.oup.com
Driver mutations can contribute to the initial processes of cancer, and their identification is
crucial for understanding tumorigenesis as well as for molecular drug discovery and …

Influence of disease-causing mutations on protein structural networks

VM Prabantu, N Naveenkumar… - Frontiers in Molecular …, 2021 - frontiersin.org
The interactions between residues in a protein tertiary structure can be studied effectively
using the approach of protein structure network (PSN). A PSN is a node-edge representation …